DTx Pharma to Participate in the 2021 BMO BioPharma Day: Spotlight on Rare Disease and Ophthalmology
San Diego – June 16, 2021 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]